Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
American Journal of Hematology
|
June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
Andrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Haematologica
|
September 17, 2013
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I
Srdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Blood Advances
|
April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Blood Advances
|
March 29, 2022
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia
Saar Gill, Vanessa Vides, Noelle V Frey, et al.
Transplantation and Cellular Therapy
|
September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
Makda Getachew Zewde, George Morales, Isha Gandhi, et al.
Blood Advances
|
February 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia
Jason Xu, Michael McCoy, Zachary Martinez, et al.
Transplantation and Cellular Therapy
|
January 19, 2024
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients
Anthony D Sung, Thuy Koll, Shannon H Gier, et al.
Blood Immunology & Cellular Therapy
|
May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM
Yu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Blood Advances
|
July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC
Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Journal for Immunotherapy of Cancer
|
April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy
Regina M Myers, Amanda M DiNofia, Yimei Li, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
American Journal of Hematology
|
June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
Andrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Haematologica
|
September 17, 2013
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I
Srdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Blood Advances
|
April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Blood Advances
|
March 29, 2022
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia
Saar Gill, Vanessa Vides, Noelle V Frey, et al.
Transplantation and Cellular Therapy
|
September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
Makda Getachew Zewde, George Morales, Isha Gandhi, et al.
Blood Advances
|
February 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia
Jason Xu, Michael McCoy, Zachary Martinez, et al.
Transplantation and Cellular Therapy
|
January 19, 2024
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients
Anthony D Sung, Thuy Koll, Shannon H Gier, et al.
Blood Immunology & Cellular Therapy
|
May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM
Yu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Blood Advances
|
July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC
Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Journal for Immunotherapy of Cancer
|
April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy
Regina M Myers, Amanda M DiNofia, Yimei Li, et al.
Page
of 11